Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Picard MedicalPMI +2.93%4 3-1 Month Momentum % is -9.87% as of Aug. 13, 2026. GuruFocus rates PMI with a GF Score™ of 4/100. The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Picard Medical ranks worse than 61.9% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-13), Picard Medical's 3-1 Month Momentum % is -9.87%.
The industry rank for Picard Medical's 3-1 Month Momentum % or its related term are showing as below:
PMI's 3-1 Month Momentum % is ranked worse than 61.9% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: -6.59
vs PMI: -9.87
Picard Medical (AMEX:PMI) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Picard Medical 3-1 Month Momentum % Related Terms
PMI vs SINT, HSCS, CODX: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Picard Medical's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Picard Medical 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Picard Medical's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Picard Medical's 3-1 Month Momentum % falls into.
Picard Medical (AMEX:PMI) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Picard Medical (PMI) has a 3-1 Month Momentum % of -9.87% as of Aug. 13, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Picard Medical and its competitors. According to the industry distribution chart, Picard Medical ranks #528 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 61.9%.
Is Picard Medical's 3-1 Month Momentum % too high?
Picard Medical's current 3-1 Month Momentum % is -9.87%. Based on the distribution chart, Picard Medical ranks #528 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Picard Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Picard Medical's 3-1 Month Momentum % compare to SINT and HSCS?
According to the Medical Devices & Instruments industry distribution chart, Picard Medical ranks #528 out of 853 companies for 3-1 Month Momentum %. This places Picard Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Picard Medical and its competitors. Picard Medical's current 3-1 Month Momentum % is -9.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Picard Medical stock overvalued right now?
Picard Medical (PMI) has a current 3-1 Month Momentum % of -9.87%. The current 3-1 Month Momentum % is -9.87%. Picard Medical's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Picard Medical (PMI), the current 3-1 Month Momentum % is -9.87% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
4GF Score
Get the complete analysis for PMI
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMI has been successfully added to your 
